{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:13:17Z","timestamp":1792113197810,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:00:00Z","timestamp":1728086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journalofhospitalinfection.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jhin.2024.09.016","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T02:39:41Z","timestamp":1728095981000},"page":"9-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Hospitalized patients on proton pump inhibitors for stress ulcer prophylaxis have a higher risk of Clostridioides difficile infection compared with those on histamine-2 receptor antagonists"],"prefix":"10.1016","volume":"154","author":[{"given":"L-H.","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-L.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-H.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-C.","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-H.K.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-J.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-L.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2024.09.016_bib1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/cc1071","article-title":"The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients","volume":"5","author":"Cook","year":"2001","journal-title":"Crit Care"},{"key":"10.1016\/j.jhin.2024.09.016_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ajhp\/56.4.347","volume":"56","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jhin.2024.09.016_bib3","unstructured":"Stress ulcer prophylaxis. The Eastern Association for the Surgery of Trauma. Available at: https:\/\/www.east.org\/education-resources\/practice-management-guidelines\/details\/stress-ulcer-prophylaxis [last accessed December 2023]."},{"key":"10.1016\/j.jhin.2024.09.016_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intens Care Med"},{"key":"10.1016\/j.jhin.2024.09.016_bib5","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10096-019-03539-6","article-title":"Clostridium difficile infection: review","volume":"38","author":"Czepiel","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jhin.2024.09.016_bib6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jcrc.2014.06.025","article-title":"Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada","volume":"29","author":"Barletta","year":"2014","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.jhin.2024.09.016_bib7","first-page":"241","article-title":"Clostridium difficile infection in an urban medical center: five-year analysis of infection rates among adult admissions and association with the use of proton pump inhibitors","volume":"37","author":"Jayatilaka","year":"2007","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.jhin.2024.09.016_bib8","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1111\/j.1572-0241.2008.01975.x","article-title":"Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients","volume":"103","author":"Aseeri","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhin.2024.09.016_bib9","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1012413","article-title":"Host and pathogen factors for Clostridium\u00a0difficile infection and colonization","volume":"365","author":"Loo","year":"2011","journal-title":"N\u00a0Engl J Med."},{"key":"10.1016\/j.jhin.2024.09.016_bib10","doi-asserted-by":"crossref","first-page":"696.e11","DOI":"10.1016\/j.jcrc.2014.03.002","article-title":"Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea","volume":"29","author":"Buendgens","year":"2014","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.jhin.2024.09.016_bib11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/jamainternmed.2013.14673","article-title":"Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit","volume":"174","author":"MacLaren","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jhin.2024.09.016_bib12","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/jgh.14983","article-title":"Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: a 15-year hospital cohort study using a\u00a0common data model","volume":"35","author":"Seo","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhin.2024.09.016_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176797","article-title":"The emergence of Clostridium difficile infection in Asia: a systematic review and meta-analysis of incidence and impact","volume":"12","author":"Borren","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jhin.2024.09.016_bib14","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.26.2100704","article-title":"A\u00a0point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018","volume":"27","author":"Viprey","year":"2022","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jhin.2024.09.016_bib15","first-page":"347","article-title":"ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998","volume":"56","author":"Pharmacists","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jhin.2024.09.016_bib16","unstructured":"MOHW. National Health Insurance Research Database. Office of Science and Technology. Available at: https:\/\/dep.mohw.gov.tw\/DOS\/cp-5119-59201-113.html. [Accessed 16 October 2024]."},{"key":"10.1016\/j.jhin.2024.09.016_bib17","unstructured":"WHO. ATC\/DDD Index 2022. WHO Collaborating Center for Drug Statistics Methodology. Available at: https:\/\/www.whocc.no\/atc_ddd_index\/?code=A07AA12 [last accessed September 2022]."},{"key":"10.1016\/j.jhin.2024.09.016_bib18","unstructured":"NCHS. International classification of diseases, Tenth revision, clinical modification (ICD-10-CM). NCHS of CDC. Available at: https:\/\/www.cdc.gov\/nchs\/icd\/icd-10-cm.htm [last accessed September 2022]."},{"key":"10.1016\/j.jhin.2024.09.016_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0272-6386(03)00415-3","article-title":"Adapting the Charlson Comorbidity Index for use in patients with ESRD","volume":"42","author":"Hemmelgarn","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jhin.2024.09.016_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1198\/sbr.2009.0074","article-title":"Strictly standardized mean difference, standardized mean difference and classical t -test for the comparison of two groups","volume":"2","author":"Zhang","year":"2010","journal-title":"Stat Biopharm Res"},{"key":"10.1016\/j.jhin.2024.09.016_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jclinepi.2022.05.023","article-title":"Large variation existed in standardized mean difference estimates using different calculation methods in clinical trials","volume":"149","author":"Luo","year":"2022","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jhin.2024.09.016_bib22","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1128\/AAC.02176-12","article-title":"Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection","volume":"57","author":"Brown","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2024.09.016_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.1016\/j.jhin.2024.09.016_bib24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/EDE.0b013e3181caeb90","article-title":"To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health","volume":"21","author":"Hubbard","year":"2010","journal-title":"Epidemiology"},{"issue":"Suppl. 1","key":"10.1016\/j.jhin.2024.09.016_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000081988","article-title":"The pathogenesis of gastrointestinal bacterial overgrowth","volume":"51","author":"Husebye","year":"2005","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jhin.2024.09.016_bib26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/gut.39.1.54","article-title":"Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study","volume":"39","author":"Thorens","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.jhin.2024.09.016_bib27","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","article-title":"Systematic review of the risk of enteric infection in patients taking acid suppression","volume":"102","author":"Leonard","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhin.2024.09.016_bib28","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ajg.2012.108","article-title":"Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis","volume":"107","author":"Kwok","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhin.2024.09.016_bib29","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/CCM.0000000000001872","article-title":"Stress ucer prophylaxis","volume":"44","author":"Barletta","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jhin.2024.09.016_bib30","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/archinte.166.22.2518","article-title":"A\u00a0hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile","volume":"166","author":"Kazakova","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jhin.2024.09.016_bib31","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.167.10.1092","article-title":"Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C. difficile-associated disease","volume":"167","author":"Dubberke","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jhin.2024.09.016_bib32","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archinternmed.2010.89","article-title":"Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection","volume":"170","author":"Howell","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jhin.2024.09.016_bib33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/jama.2019.22190","article-title":"Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine-2 receptor blockers on in-hospital mortality among ICU patients receiving invasive mechanical ventilation: the PEPTIC randomized clinical trial","volume":"323","author":"Young","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jhin.2024.09.016_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nrgastro.2014.235","article-title":"Stress-related mucosal disease in the critically ill patient","volume":"12","author":"Bardou","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhin.2024.09.016_bib35","article-title":"Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline","volume":"368","author":"Ye","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jhin.2024.09.016_bib36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jcrc.2009.05.014","article-title":"Overuse of stress ulcer prophylaxis in the critical care setting and beyond","volume":"25","author":"Farrell","year":"2010","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.jhin.2024.09.016_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/microorganisms11010044","article-title":"Molecular epidemiology, clinical course, and implementation of specific hygiene measures in hospitalised patients with Clostridioides difficile infection in Brandenburg, Germany","volume":"11","author":"Dirks","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.jhin.2024.09.016_bib38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cgh.2009.12.022","article-title":"Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy","volume":"8","author":"Lombardo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhin.2024.09.016_bib39","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile Infection","volume":"372","author":"Leffler","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhin.2024.09.016_bib40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40121-024-00922-5","article-title":"Association between risk of clostridium difficile infection\u00a0and duration of proton pump inhibitor or H2-receptor antagonist use in hospitalized patients","volume":"13","author":"Huang","year":"2024","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jhin.2024.09.016_bib41","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00003246-199602000-00026","article-title":"Prophylaxis for stress-related gastrointestinal hemorrhage: a cost effectiveness analysis","volume":"24","author":"Ben-Menachem","year":"1996","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jhin.2024.09.016_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5056\/jnm.2013.19.1.25","article-title":"Pharmacokinetics and pharmacodynamics of the proton pump inhibitors","volume":"19","author":"Shin","year":"2013","journal-title":"J\u00a0Neurogastroenterol Motil"},{"key":"10.1016\/j.jhin.2024.09.016_bib43","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2036.2008.03924.x","article-title":"Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting","volume":"29","author":"Dalton","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhin.2024.09.016_bib44","unstructured":"NIHA. Medical expense declaration and payment of Taiwan National Health Insurance. National health insurance administration, Taiwan Ministry of Health and Welfare. Available at: https:\/\/www.nhi.gov.tw\/ch\/np-2750-1.html [last accessed July 2024]."},{"key":"10.1016\/j.jhin.2024.09.016_bib45","first-page":"157","article-title":"Accuracy of diabetes diagnosis in health insurance claims data in Taiwan","volume":"104","author":"Lin","year":"2005","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.jhin.2024.09.016_bib46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pds.2087","article-title":"Validation of the\u00a0national health insurance research database with ischemic\u00a0stroke cases in Taiwan","volume":"20","author":"Cheng","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jhin.2024.09.016_bib47","first-page":"500","article-title":"Validation of acute myocardial infarction cases in the national health insurance research database in Taiwan","volume":"24","author":"Cheng","year":"2014","journal-title":"J\u00a0Epidemiol"},{"key":"10.1016\/j.jhin.2024.09.016_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2015.07.075","article-title":"Validity of in-hospital mortality data among patients with acute myocardial infarction or stroke in National Health Insurance Research Database in Taiwan","volume":"201","author":"Cheng","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jhin.2024.09.016_bib49","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/pds.4267","article-title":"Validity of cancer diagnosis in the National Health Insurance database compared with the linked National Cancer Registry in Taiwan","volume":"27","author":"Kao","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jhin.2024.09.016_bib50","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhin.2024.09.016_bib51","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/aje\/kwp107","article-title":"Competing risk regression models for epidemiologic data","volume":"170","author":"Lau","year":"2009","journal-title":"Am J Epidemiol"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670124003244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670124003244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:44:53Z","timestamp":1732409093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670124003244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":51,"alternative-id":["S0195670124003244"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2024.09.016","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hospitalized patients on proton pump inhibitors for stress ulcer prophylaxis have a higher risk of Clostridioides difficile infection compared with those on histamine-2 receptor antagonists","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2024.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society.","name":"copyright","label":"Copyright"}]}}